Revolutionizing Drug Development: How the GUIDE Program Generates Antibodies to Keep Us Safe @LivermoreLab
Revolutionizing Drug Development: How the GUIDE Program Generates Antibodies to Keep Us Safe  @LivermoreLab
Uploaded December 2024 | Updated November 2026, 1 day ago
GUIDE aims to leverage its integrated computational and experimental capabilities to accelerate drug development for the warfighter by harnessing the power of advanced simulation and machine learning. GUIDE is an interagency program between the DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) Joint Project Lead for CBRND Enabling Biotechnologies (JPL EB), the Department of Energy, other interagency, academic, and industry partners.

IM: LLNL-VIDEO-2000953
Revolutionizing Drug Development: How the GUIDE Program Generates Antibodies to Keep Us SafeBig Ideas Lab | Planetary Defense (Part 1)Big Ideas Lab | DronesLLNL leads new DART Mission paper on inferring asteroid material properties from deflection testSpider-Inspired Technology Inside the Worlds Most Energetic LaserHackathon Puts Machine Learning in the Driver’s SeatMeet Audrey Eshun | #WomenScienceDay #ShortsBig Ideas Lab | ImplantablesThe OS-150 Robotics Laboratory Takes FlightBig Ideas Lab | Space SecurityBig Ideas Lab | The Postdoc JourneyLLNL: Engineering the Future
Lawrence Livermore National Laboratory |

Revolutionizing Drug Development: How the GUIDE Program Generates Antibodies to Keep Us Safe

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER